Glecaprevir-impurities | Pharmaffiliates

Glecaprevir and its Impurities

Glecaprevir is being developed as a treatment of chronic hepatitis C infection in co-formulation with an HCV NS5A inhibitor pibrentasvir. Reference standards of Glecaprevir API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 4 results for Glecaprevir Impurities
PA 07 0850000

Glecaprevir - API

Glecaprevir


  • Catalogue No.:PA 07 0850000

  • CAS :

    1365970-03-1

  • Molecular Formula : C38H46F4N6O9S

  • Molecular Weight : 838.87

PA 07 0851000

(1R,2R)-1-Amino-2-(difluoromethyl)-N-[(1-methylcyclopropyl)sulfonyl]cyclopropanecarboxamide Hydrochloride

(1R,2R)-1-Amino-2-(difluoromethyl)-N-[(1-methylcyclopropyl)sulfonyl]cyclopropanecarboxamide Hydrochloride


  • Catalogue No.:PA 07 0851000

  • CAS :

    1360828-80-3

  • Molecular Formula : C9H15ClF2N2O3S

  • Molecular Weight : 304.74

PA 07 0851001

1-Hydroxy-2(1H)-pyridinone

1-Hydroxy-2(1H)-pyridinone


  • Catalogue No.:PA 07 0851001

  • CAS :

    822-89-9

  • Molecular Formula : C5H5NO2

  • Molecular Weight : 111.1

PA STI 089297

Glecaprevir-13C,D3

Glecaprevir-13C,D3


  • Catalogue No.:PA STI 089297

  • CAS :

    NA

  • Molecular Formula : C38H43D3F4N6O9S

  • Molecular Weight : 841.89